# Franklin Ethereum Trust: overview
EZET · CBOE · CIK 2011535 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31
Pages: [Overview](/companies/ezet.md) · [Financials](/companies/ezet/financials.md) · [Filings](/companies/ezet/filings.md) · [Insiders](/companies/ezet/insiders.md)
Revenue is not reported in this company’s XBRL financial statements.
## Last eight quarters
| Line item | Unit | Q3 FY2026 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported |
- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.
## Last five fiscal years
| Line item | Unit | FY2026 (2026-03-31) |
| --- | --- | ---: |
| Revenue | $ | not reported |
| Gross margin | % | not reported |
| Operating margin | % | not reported |
| Net margin | % | not reported |
| Diluted EPS | $ per share | not reported |
| Free cash flow | $ | not reported |
- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.
Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.
## Insider purchases and sales
The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ezet/insiders.md)
None in coverage.
## Funds that report holding it
From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Cetera Investment Advisers](/funds/1666741.md) | 2026-06-30 | $799.2k | 66,791 | | Added +6,439 |
| [MEITAV INVESTMENT HOUSE LTD](/funds/1398346.md) | 2026-06-30 | $665.6k | 55,626 | | Added +2,778 |
| [FAS Wealth Partners, Inc.](/funds/1596957.md) | 2026-06-30 | $296.6k | 24,785 | | Not compared |
| [GW HENSSLER & ASSOCIATES LTD](/funds/1080369.md) | 2026-06-30 | $144.1k | 12,046 | | New +12,046 |
| [Jacobs Equity LLC](/funds/2111761.md) | 2026-06-30 | $125.2k | 10,463 | | New +10,463 |
| [Sanctuary Advisors, LLC](/funds/1777271.md) | 2026-06-30 | $122.8k | 10,262 | | New +10,262 |
| [CWM, LLC](/funds/1535847.md) | 2026-03-31 | $39.1k | 2,461 | | Not compared |
| [FIDUCIARY FINANCIAL ADVISORS](/funds/2116119.md) | 2026-06-30 | $39.1k | 3,265 | | New +3,265 |
| [Geneos Wealth Management Inc.](/funds/1764754.md) | 2026-06-30 | $23.1k | 1,932 | | Unchanged |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $14.4k | 1,200 | | Unchanged |
## Recent filings
[All 62 filings](/companies/ezet/filings.md)
| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 21:18 ET | [10-Q](/filings/0001140361-26-033204.md) | Quarterly report, period 2026-06-30 | 0001140361-26-033204 |
| 2026-06-29 | 20:58 ET | [10-K](/filings/0001140361-26-026753.md) | Annual report, period 2026-03-31 | 0001140361-26-026753 |
| 2026-05-08 | 20:10 ET | [8-K](/filings/0001193125-26-214636.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-214636 |
| 2026-02-17 | 21:23 ET | [10-Q](/filings/0001140361-26-005778.md) | Quarterly report, period 2025-12-31 | 0001140361-26-005778 |
| 2025-11-13 | 19:56 ET | [10-Q](/filings/0001140361-25-041936.md) | Quarterly report, period 2025-09-30 | 0001140361-25-041936 |
| 2025-08-14 | 21:47 ET | [10-Q](/filings/0001140361-25-030870.md) | Quarterly report, period 2025-06-30 | 0001140361-25-030870 |
| 2025-06-30 | 10:03 ET | [10-K](/filings/0001140361-25-024064.md) | Annual report, period 2025-03-31 | 0001140361-25-024064 |
| 2025-02-12 | 21:53 ET | [10-Q](/filings/0001140361-25-004062.md) | Quarterly report, period 2024-12-31 | 0001140361-25-004062 |
| 2024-11-12 | 19:51 ET | [10-Q](/filings/0001193125-24-255764.md) | Quarterly report, period 2024-09-30 | 0001193125-24-255764 |
| 2024-08-14 | 20:55 ET | [10-Q](/filings/0001193125-24-200706.md) | Quarterly report, period 2024-06-30 | 0001193125-24-200706 |
## Latest annual report
[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001140361-26-026753.md), filed Jun 29, 2026.
## Forecast league
Not in this season’s league. [This season’s league](/leagues.md)
## About the filer
- CIK: 2011535
- Tickers: EZET
- Exchange: CBOE
- SIC code: 6221 Commodity Contracts Brokers & Dealers
- State of incorporation: DE
- Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.